CGEM FY 2020 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$841M

FY 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$62,000

Operating Income

-$60M

Net Income

-$52M

EPS (Diluted)

$-1.19

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$215M

Total Liabilities

$14M

Stockholders' Equity

$199M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$62,000	-$70,000	+11.4%
Operating Income	-$60M	-$22M	-170.9%
Net Income	-$52M	-$20M	-158.5%